首页> 外文会议>ASME International Mechanical Engineering Congress and Exposition >The study on PLLA-nanodiamond composites for surgical fixation devices
【24h】

The study on PLLA-nanodiamond composites for surgical fixation devices

机译:用于外科固定装置PLLA-纳米金刚石复合材料的研究

获取原文

摘要

Biopolymers have a great potential in biomedical engineering, having been used as scaffolds for hard and soft tissues, such as bone and blood vessels for many years. More recently biopolymers have also found applications in surgical fixation devices. Compared with conventional metal fixation devices, bone grafts and organ substitutes, biopolymer products have advantages of no long-term implant palpability or temperature sensitivity, predictable degradation to provide progressive bone loading and no stress shielding, all of which leads to a better bone healing, reduced patient trauma and cost, elimination of second surgery for implant removal, and fewer complications from infections. However lack of initial fixation strength and bioactivity are two major concerns which limited more widespread applications of biopolymers in orthopedic surgery. Nanodiamond is attractive for its use in reinforcement of composite materials due to their outstanding mechanical, chemical and biological properties. Nanotechnology shows us many innovations and it is generally accepted view that many could be further developed and applied in tissue engineering. In this work, we conduct poly(L-lactic acid) (PLLA) and octadecylamine functionalized nanodiamond (ND-ODA) composite research to optimize the polymer/ND interface, thus to reinforce the mechanical strength. Composites comprising PLLA matrix with embedded ND-ODA were prepared by mixing PLLA/chloroform solution with chloroform suspension of nanodiamonds at concentrations of 0-10 by weight percent. The dispersion of ND-ODA was observed by transmission electron microscopy (TEM). TEM micrographs show that ND-ODA can disperse uniformly in PLLA till 10% wt. Nanoindentation result shows the mechanical strength of ND-ODA/PLLA composites improving following increasing the concentration of ND-ODA in composites. The noncytotoxicity of ND-ODA was demonstrated on 7F2 Osteoblasts. To test the usefulness of ND-ODA/PLLA composites as scaffolds for supporting cell growth, 7F2 Osteoblasts were cultured on scaffolds for 6 days. The attachment and proliferation of 7F2 on all scaffolds were assessed by fluorescent nuclear staining with Hoechst 33258 and Alamar BlueTM assay. The results showed that the adding ND-ODA does small influence cell growth, which indicates the composites have good biocompatibility. The morphology of 7F2 cells growing on all ND-ODA/PLLA composite scaffolds was determined by SEM, which confirms the Osteoblasts spread on the scaffolds. All these results combined suggest that ND-ODA/PLLA might provide a novel composite suitable for surgical fixation devices.
机译:生物聚合物具有巨大的生物医学工程潜力,已被用作硬组织的支架,例如骨骼和血管多年。最近,最近的生物聚合物也发现了手术固定装置中的应用。与常规金属固定装置,骨移植物和器官替代品相比,生物聚合物产物具有长期植入物的优点,可预测骨负荷和不带应力屏蔽的可预测降解,所有这些都会导致更好的骨愈合,减少患者创伤和成本,消除植入物去除的第二次手术,感染较少的并发症。然而,缺乏初始固定强度和生物活性是两个主要问题,这些主要问题是生物聚合物在整形外科手术中的更广泛应用。由于其出色的机械,化学和生物特性,纳米金刚胺对于加固复合材料的使用具有吸引力。纳米技术向我们展示了许多创新,并且普遍认为许多人可以进一步开发和应用于组织工程。在这项工作中,我们进行聚(L-乳酸)(PLLA)和十八烷基胺官能化纳米金刚胺(ND-ODA)复合研究,以优化聚合物/ ND界面,从而加强机械强度。通过将PLLA /氯仿溶液用氯仿悬浮液混合在0-10重量%的浓度为0-10重量%的浓度,通过将PLLA /氯仿溶液混合来制备包含嵌入式ND-ODA的复合材料。通过透射电子显微镜(TEM)观察ND-ODA的分散体。 TEM显微照片显示ND-ODA可以在PLLA均匀分散到10%wt。纳米狭窄结果表明,在增加复合材料中增加ND-ODA的浓度后,ND-ODA / PLLA复合材料的机械强度。在7F2成骨细胞上证明了ND-ODA的非胞素毒性。为了测试ND-ODA / PLLA复合材料的用途作为支撑细胞生长的支架,将7F2成骨细胞培养在支架上6天。通过Hoechst 33258和Alamar Bluetm测定,通过荧光核染色和Alamar Bluetm测定来评估所有支架上7F2的附着和增殖。结果表明,添加的ND-ODA对细胞生长具有小的影响,表明复合材料具有良好的生物相容性。通过SEM测定生长在所有ND-ODA / PLLA复合支架上的7F2细胞的形态,其证实了成骨细胞在支架上传播。所有这些结果相结合表明ND-ODA / PLLA可以提供适合手术固定装置的新型复合材料。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号